Endoscopic Submucosal Dissection Market Size & Growth Forecast 2027–2036, By Segments (End Use, Product, Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Endoscopic Submucosal Dissection Market size was around USD 413.5 million in 2026 and is slated to grow at a 5.13% CAGR from 2027 to 2036, crossing USD 681.93 million by 2036. The industry revenue for 2027 is calculated at USD 431.36 million.
Get more details on this report
Request Free Sample ReportEndoscopic Submucosal Dissection Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 42.51% market share in 2026, supported by advanced endoscopy infrastructure, experienced providers, high procedural volumes, and strong adoption of specialized minimally invasive techniques.
- Asia Pacific is projected to grow at a 6.33% CAGR, driven by rising procedural adoption, expanding endoscopic capabilities, increasing preference for minimally invasive treatment, and broader use in gastrointestinal care.
Segment Momentum
- Hospitals held a 59.12% share in 2026 because they provide the specialized staff, advanced endoscopy infrastructure, and integrated care needed to manage diagnosis, treatment, and follow-up within one setting.
- Knives are the fastest-growing product segment because increasing emphasis on procedural precision and operator control is driving demand for specialized instruments that improve cutting accuracy and workflow efficiency.
Market Expansion Drivers
- Rising gastrointestinal cancer prevalence increasing demand for minimally invasive ESD procedures.
- Advancements in endoscopic instruments improving precision and curative resection outcomes.
- AI-assisted lesion detection and procedural planning enhancing adoption of advanced ESD platforms.
Leading Market Participants
- Prominent players in the endoscopic submucosal dissection market include Olympus Corporation (Japan), Boston Scientific Corporation (United States), Medtronic plc (Ireland), FUJIFILM Holdings Corporation (Japan), HOYA Corporation (Japan), Karl Storz SE & Co. KG (Germany), Cook Group Incorporated (United States), CONMED Corporation (United States), STERIS plc (Ireland), Creo Medical Group plc (United Kingdom).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 413.5 million
- 2027 Estimated Market Size: USD 431.36 million.
- Projected Market Size: USD 681.93 million by 2036
- Growth Forecast: 5.13% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals (End Use) | Gastroscopes and Colonoscopes (Product) | Gastric Cancer (Indication)
- Emerging Opportunity Segment: Hospitals (End Use) | Knives (Product) | Colorectal Cancer (Indication)
Market Growth Drivers and Industry Trends
Rising gastrointestinal cancer prevalence increasing demand for minimally invasive ESD procedures
The growing incidence of gastrointestinal cancers is increasing the need for effective treatment approaches that can remove early-stage lesions while limiting surgical trauma. Rising demand will drive the endoscopic submucosal dissection market as ESD enables physicians to remove larger and more complex gastrointestinal lesions in a minimally invasive manner while preserving surrounding tissue. The procedure is particularly valuable for lesions that require precise removal and histological assessment, supporting accurate evaluation of tumor characteristics and reducing the need for more extensive surgical interventions in appropriate patients. Increasing clinical awareness of early diagnosis and the benefits of organ-preserving treatment is also encouraging the use of advanced endoscopic techniques across specialized gastrointestinal care settings.
Advancements in endoscopic instruments improving precision and curative resection outcomes
Continuous innovation in endoscopic knives, injection systems, hemostatic devices, visualization technologies, and accessory instruments is improving procedural control during complex lesion removal. The endoscopic submucosal dissection market will benefit from these advancements as improved instrument design enables endoscopists to perform controlled dissection, manage bleeding, and navigate challenging anatomical locations with greater precision. Enhanced visualization and ergonomic instruments can also support more consistent manipulation during lengthy procedures, while specialized accessories help physicians address different lesion characteristics and procedural requirements. These developments are contributing to broader clinical confidence in ESD as a therapeutic option for appropriately selected gastrointestinal lesions.
AI-assisted lesion detection and procedural planning enhancing adoption of advanced ESD platforms
Artificial intelligence is increasingly being incorporated into gastrointestinal endoscopy to support lesion identification, characterization, and procedure planning. AI-assisted technologies will propel the endoscopic submucosal dissection market by helping clinicians identify suspicious lesions and assess features that may influence treatment selection and resection strategy. Computer-assisted image analysis can support more consistent interpretation of endoscopic findings, while AI-based tools may assist physicians in defining lesion boundaries and evaluating characteristics relevant to procedural planning. Integration of these capabilities with advanced imaging and endoscopic platforms can help streamline clinical workflows and provide additional decision support during the assessment of complex gastrointestinal lesions.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising gastrointestinal cancer prevalence increasing demand for minimally invasive ESD procedures | 2.00% | High | North America, Asia Pacific | High | Near Term |
| Advancements in endoscopic instruments improving precision and curative resection outcomes | 1.70% | Moderate | North America, Europe | High | Mid Term |
| AI-assisted lesion detection and procedural planning enhancing adoption of advanced ESD platforms | 1.40% | Moderate | Asia Pacific, Europe | Emerging | Long Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America held the largest share of the endoscopic submucosal dissection market in 2026, accounting for 42.51% share, supported by advanced gastrointestinal care infrastructure, high adoption of minimally invasive procedures, and strong clinical awareness of endoscopic treatment approaches. The region benefits from the availability of sophisticated endoscopy systems, experienced specialists, and established healthcare facilities capable of performing complex therapeutic procedures. Growing emphasis on early detection and treatment of gastrointestinal disorders, combined with patient preference for less invasive interventions, is strengthening demand for advanced endoscopic techniques. Continued investment in procedural capabilities and improvements in endoscopic technology further reinforce the region's leading position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to be the fastest-growing region in the endoscopic submucosal dissection market, driven by expanding healthcare infrastructure, rising awareness of gastrointestinal diseases, and increasing adoption of minimally invasive treatment methods. Improvements in diagnostic capabilities are enabling earlier identification of lesions that may be suitable for endoscopic intervention, while healthcare modernization is increasing access to specialized procedures. A growing patient population requiring gastrointestinal care and rising investments in advanced medical equipment are also supporting adoption. As clinical expertise expands and hospitals strengthen their endoscopic treatment capabilities, demand for endoscopic submucosal dissection is expected to gain momentum across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Specialized Endoscopy ServicesGermany is strengthening endoscopic submucosal dissection capabilities through specialized gastrointestinal centers focused on minimally invasive treatment. Healthcare providers are prioritizing advanced imaging technologies and procedural expertise to improve clinical efficiency.
France 🇫🇷
Gastrointestinal Procedure EnhancementFrance is increasing the use of endoscopic submucosal dissection within specialized digestive care programs to reduce reliance on more invasive surgical approaches. Hospitals are investing in clinician expertise and precision endoscopic technologies to improve procedural consistency.
Italy 🇮🇹
Endoscopic Care DevelopmentItaly is strengthening endoscopic submucosal dissection services by expanding access to specialized gastrointestinal treatment within hospital networks. Clinical teams are adopting advanced endoscopy platforms and focused training to improve procedural efficiency and patient care.
Japan 🇯🇵
Clinical Technique AdvancementJapan continues to refine endoscopic submucosal dissection through extensive clinical expertise and ongoing procedural innovation. Medical institutions are emphasizing advanced endoscopic technologies and specialized training to enhance treatment quality for gastrointestinal conditions.
South Korea 🇰🇷
Endoscopy Innovation AdoptionSouth Korea is expanding endoscopic submucosal dissection across tertiary hospitals as demand grows for minimally invasive gastrointestinal interventions. Healthcare providers are integrating advanced endoscopic systems that improve procedural accuracy and clinical workflow efficiency.
United States 🇺🇸
Advanced Minimally Invasive CareU.S. healthcare providers are expanding endoscopic submucosal dissection procedures to improve treatment options for early gastrointestinal lesions. Hospitals are investing in specialized endoscopic equipment and physician training to support procedural precision and patient outcomes.
Segment Leadership and Growth Trends
Endoscopic Submucosal Dissection Market Share (%), by End Use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd Use Segment Analysis: Hospitals (Largest & Fastest-Growing Segment)
Hospitals led the endoscopic submucosal dissection market in 2026 with a 59.12% share and remained the fastest-growing end-use segment, reflecting their central role in performing advanced gastrointestinal procedures. The availability of specialized endoscopy units, trained clinical personnel, diagnostic infrastructure, and comprehensive patient-care capabilities supports the concentration of these procedures within hospital settings. Increasing adoption of minimally invasive approaches and greater emphasis on precise lesion removal are further strengthening demand for endoscopic submucosal dissection capabilities. Hospitals' ability to integrate diagnosis, intervention, and follow-up care within established clinical pathways also supports continued segment expansion.
Product Segment Analysis: Gastroscopes and Colonoscopes (Largest Segment) vs Knives (Fastest-Growing Segment)
Gastroscopes and colonoscopes accounted for the largest share of the endoscopic submucosal dissection market in 2026, representing 33.92% of the market, supported by their fundamental role in visualizing and accessing gastrointestinal lesions during endoscopic procedures. Growing utilization of minimally invasive gastrointestinal interventions is increasing demand for advanced visualization equipment capable of supporting accurate lesion assessment and procedural guidance. Improvements in endoscopic imaging, procedural precision, and clinical workflow are also reinforcing the importance of these devices within endoscopic submucosal dissection procedures.
Knives are emerging as the fastest-growing product segment, supported by their direct role in tissue incision and dissection during endoscopic submucosal procedures. Increasing adoption of techniques designed to achieve controlled and precise lesion removal is creating stronger demand for specialized cutting instruments. Greater procedural experience, advances in endoscopic intervention, and the growing focus on efficient tissue dissection are further supporting the adoption of advanced knives.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End Use | Hospitals, Specialty Clinics, Others | Hospitals | Hospitals |
| Product | Gastroscopes and Colonoscopes, Knives, Injection Agents, Tissue Retractors, Graspers/ Clips, Others | Gastroscopes and Colonoscopes | Knives |
| Indication | Esophageal Cancer, Gastric Cancer, Colorectal Cancer, Others | Gastric Cancer | Colorectal Cancer |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Leading companies in the endoscopic submucosal dissection market:
1. Olympus Corporation (Japan)
2. Boston Scientific Corporation (United States)
3. Medtronic plc (Ireland)
4. FUJIFILM Holdings Corporation (Japan)
5. HOYA Corporation (Japan)
6. Karl Storz SE & Co. KG (Germany)
7. Cook Group Incorporated (United States)
8. CONMED Corporation (United States)
9. STERIS plc (Ireland)
10. Creo Medical Group plc (United Kingdom)
Technological refinement in minimally invasive procedures is significantly influencing the endoscopic submucosal dissection market. Advanced visualization systems, precision instruments, and ergonomic device designs are being developed to improve procedural efficiency and patient safety. Continued investment in clinical research and procedural training is also supporting wider adoption of sophisticated endoscopic treatment techniques.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Olympus Corporation (Japan) | |||||||
| Boston Scientific Corporation (United States) | |||||||
| Medtronic plc (Ireland) | |||||||
| FUJIFILM Holdings Corporation (Japan) | |||||||
| HOYA Corporation (Japan) | |||||||
| Karl Storz SE & Co. KG (Germany) | |||||||
| Cook Group Incorporated (United States) | |||||||
| CONMED Corporation (United States) | |||||||
| STERIS plc (Ireland) | |||||||
| Creo Medical Group plc (United Kingdom). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Olympus | May-26 | Olympus entered a global distribution collaboration with EndoRobotics to integrate robot-assisted endoscopic systems into its portfolio. This partnership significantly expands the company’s presence in next-generation, minimally invasive gastrointestinal surgical technologies and provides a scalable distribution channel for advanced endoscopic procedural solutions. |
| EndoQuest Robotics | Sep-25 | EndoQuest Robotics completed the first fully robotic endoscopic submucosal dissection using its proprietary endoluminal system. This clinical milestone validates the operational viability of robotic-assisted gastrointestinal surgery and represents a significant technical advancement toward commercializing autonomous or semi-autonomous platforms for complex minimally invasive interventions. |
| Olympus | Sep-25 | Olympus launched the OLYSENSE CAD/AI portfolio in the U.S. and European markets, providing cloud-based, AI-powered tools for real-time lesion detection. This integration of artificial intelligence into endoscopy workflows enhances diagnostic accuracy and operational efficiency, reflecting the company's strategic push to digitize and improve clinical outcomes in complex gastrointestinal procedures. |
| EndoQuest Robotics | Jul-25 | EndoQuest Robotics secured a Series D-2 funding round led by Crescent Enterprises and Dr. Fred Moll. This capital injection is earmarked for accelerating clinical trials and regulatory approval processes for its robotic endoluminal surgical system, directly supporting the commercialization trajectory of new robotic technologies for gastrointestinal and endoluminal surgery. |
| Fujifilm | Jul-25 | Fujifilm launched the ELUXEO 8000 system and 800 Series endoscopes, upgrading its high-performance imaging platform for gastrointestinal procedures. The launch reinforces the company’s competitive positioning in advanced visualization, providing clinicians with improved imaging capabilities essential for the precision required in complex endoscopic submucosal dissection and related therapeutic interventions. |
| Fujifilm | Apr-24 | Fujifilm introduced the Tracmotion device, an endoscopic tool designed for single-operator use in ESD procedures. Featuring 360° rotatable retraction, the device addresses critical functional challenges in tissue manipulation during complex dissections, representing a targeted innovation to improve procedural efficiency and clinical outcomes in advanced gastrointestinal surgeries. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Endoscopic Submucosal Dissection Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Physician Specialty | Gastroenterologists, General Surgeons, Colorectal Surgeons, Other Endoscopic Specialists |
| Reimbursement Coverage | Fully Reimbursed Procedures, Partially Reimbursed Procedures, Self-Pay Procedures, Unreimbursed Procedures |
| Technology Integration | Conventional ESD Systems, High-Definition Imaging Integration, Artificial Intelligence-Assisted Systems, Robotic & Advanced Navigation Systems |
Endoscopic Submucosal Dissection Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Gastroenterology Treatment Pathway Analysis |
|
| Hospital Infrastructure Readiness Assessment |
|
| Advanced Endoscopy Service Expansion Opportunities |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the endoscopic submucosal dissection market?
How is the endoscopic submucosal dissection industry size expected to evolve during the forecast period?
How is rising gastrointestinal cancer prevalence driving adoption of minimally invasive endoscopic submucosal dissection procedures?
How are advancements in endoscopic instruments improving adoption and clinical outcomes in ESD procedures?
Why are hospitals the leading end-use segment in the endoscopic submucosal dissection market?
Why are knives the fastest-growing product segment in the endoscopic submucosal dissection market?
What supports North America's leadership in the endoscopic submucosal dissection market?
Why is Asia Pacific emerging as the fastest-growing endoscopic submucosal dissection market?
Which companies are driving growth in the endoscopic submucosal dissection landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization